Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors

被引:8
作者
Bai, Lan-jun [1 ,2 ]
Liu, Qing [3 ,4 ]
Wang, Min [5 ,6 ]
Loo, Wings T. Y. [3 ,4 ,7 ,8 ]
Cheng, Rebecca W. Y. [8 ]
Chow, Louis W. C. [3 ,4 ]
Cheung, Mary N. B. [3 ,4 ]
Wei, Kelly Y. R. [3 ,4 ]
Yip, Adrian Y. S. [3 ,4 ]
Ng, Elizabeth L. Y. [3 ,4 ]
机构
[1] Sichuan Acad Med Sci, Dept Stomatol, Chengdu, Sichuan Provinc, Peoples R China
[2] Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China
[3] UNIMED Med Inst, Hong Kong, Hong Kong, Peoples R China
[4] Org Oncol & Translat Res, Hong Kong, Hong Kong, Peoples R China
[5] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China
[6] Sichuan Univ, West China Hosp Stomatol, Dept Prosthodont, Chengdu, Peoples R China
[7] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China
[8] Hong Kong Inst Educ, Dept Psychol, Hong Kong, Hong Kong, Peoples R China
关键词
Posttraumatic stress disorder; Breast cancer; Biological marker; Psychological changes; Anxiety; Depression; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; INDUCED ORAL MUCOSITIS; CANCER-PATIENTS; MAJOR DEPRESSION; HONG-KONG; CORTISOL; ANXIETY; SURVIVORS; ASSOCIATIONS;
D O I
10.5301/JBM.2012.9936
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose: Posttraumatic stress disorder (PTSD) is a severe anxiety disorder developed by exposure to any incident or circumstance that results in psychological trauma. In this study we compared the psychological and physiological changes between patients with malignant and benign breast tumors. Methods: We selected 150 Chinese women with a breast mass, aged 20 to 45 years, from the Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital between 2009 and 2011 for this study; 30 healthy participants were enrolled into the control group. All subjects were examined and had their tumor mass aspirated for diagnosis. Equal numbers of patients with benign and malignant tumors were recruited. Patients with malignant tumors presented with low grade, minimal tumor invasion and non-involved lymph nodes. Questionnaires regarding anxiety, depression and PTSD were conducted 2 hours before getting the diagnostic result and 1 month after the diagnosis. Serum levels of IL-6, TNF- , cortisol and high-sensitivity C-reactive protein before and after diagnosis were investigated and compared. The number of occurrences of oral ulcerative mucositis was also recorded. Results: All patients experienced a certain degree of anxiety and their biomarkers were elevated compared with the normal reference range before the pathological report was disclosed. However, 1 month after the operation, the benign tumor group showed significantly lower levels of biomarkers and anxiety scores than patients with a malignant breast tumor. The results were consistent throughout 12 months of study. Conclusion: Study subjects with a benign tumor returned to their normal condition after being diagnosed, while patients with a malignant tumor suffered from a certain degree of PTSD or depression.
引用
收藏
页码:E322 / E330
页数:9
相关论文
共 50 条
  • [31] Benign and malignant breast tumors classification based on region growing and CNN segmentation
    Rouhi, Rahimeh
    Jafari, Mehdi
    Kasaei, Shohreh
    Keshavarzian, Peiman
    EXPERT SYSTEMS WITH APPLICATIONS, 2015, 42 (03) : 990 - 1002
  • [32] Association between estradiol, estrogen receptors, total lipids, triglycerides, and cholesterol in patients with benign and malignant breast tumors
    Mady, EA
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 75 (4-5) : 323 - 328
  • [33] Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast
    Pia Boström
    Annele Sainio
    Tanja Kakko
    Mikko Savontaus
    Mirva Söderström
    Hannu Järveläinen
    Histochemistry and Cell Biology, 2013, 139 : 161 - 171
  • [34] Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast
    Bostrom, Pia
    Sainio, Annele
    Kakko, Tanja
    Savontaus, Mikko
    Soderstrom, Mirva
    Jarvelainen, Hannu
    HISTOCHEMISTRY AND CELL BIOLOGY, 2013, 139 (01) : 161 - 171
  • [35] Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids
    Zhu, Weizhu
    Qin, Wenyi
    Hewett, John E.
    Sauter, Edward R.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (02) : 474 - 482
  • [36] Evaluation of ipsilateral increased vascularity in differentiating benign and malignant breast lesions
    Wang, Haili
    Xu, Yaping
    Yao, Zhigang
    Zhan, Haiyu
    Liu, Qingwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 4100 - 4107
  • [37] Analysis of the diagnostic efficacy of ultrasound, MRI, and combined examination in benign and malignant breast tumors
    Ma, Dianpei
    Wang, Changliang
    Li, Jie
    Hao, Xiaohan
    Zhu, Yun
    Gao, Zhizhen
    Liu, Chun
    Luo, Changfan
    Huang, Yu
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [38] Classification of Benign and Malignant Breast Tumors Using H-Scan Ultrasound Imaging
    Ouyang, Yali
    Tsui, Po-Hsiang
    Wu, Shuicai
    Wu, Weiwei
    Zhou, Zhuhuang
    DIAGNOSTICS, 2019, 9 (04)
  • [39] Biological and psychological predictors of cognitive function in breast cancer patients before surgery
    Aspelund, Snaefridur Gudmundsdottir
    Halldorsdottir, Thorhildur
    Agustsson, Gudjon
    Tobin, Hannah Ros Sigurdardottir
    Wu, Lisa M.
    Amidi, Ali
    Johannsdottir, Kamilla R.
    Lutgendorf, Susan K.
    Telles, Rachel
    Daly, Huldis Franksdottir
    Sigurdardottir, Kristin
    Heiddis, Valdimarsdottir B.
    Baldursdottir, Birna
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [40] Biological and psychological predictors of cognitive function in breast cancer patients before surgery
    Aspelund, Snaefridur Gudmundsdottir
    Halldorsdottir, Thorhildur
    Agustsson, Gudjon
    Tobin, Hannah Ros Sigurdardottir
    Wu, Lisa M.
    Amidi, Ali
    Johannsdottir, Kamilla R.
    Lutgendorf, Susan K.
    Telles, Rachel
    Daly, Huldis Franksdottir
    Sigurdardottir, Kristin
    Heiddis B., Valdimarsdottir
    Baldursdottir, Birna
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)